Skip to main content
45°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by CareDx, Inc.
< Previous
1
2
3
Next >
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
March 23, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
March 07, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Update Regarding Raymond James & Associates’ Conference
March 06, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
March 06, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Comments on MolDX Publication of New Billing and Coding Article
March 03, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit
March 01, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting
February 22, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
February 16, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
January 26, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
January 11, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
January 09, 2023
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
December 21, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Announces $50 Million Stock Repurchase Program
December 06, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
December 01, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
November 11, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx To Participate in Upcoming Investor Conferences
November 04, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Reports Third Quarter 2022 Results
November 03, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
November 02, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
November 01, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
October 27, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx to Report Third Quarter 2022 Financial Results
October 26, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
October 26, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 25, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
September 29, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions
September 27, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List
September 26, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference
September 19, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone
September 14, 2022
From
CareDx, Inc.
Via
Business Wire
Tickers
CDNA
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.